Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,875.00
+130.00 (2.74%)
At close: Oct 31, 2025

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
63,11198,001191,588---
Upgrade
Market Cap Growth
-44.49%-48.85%----
Upgrade
Enterprise Value
53,55780,945164,210---
Upgrade
Last Close Price
4875.007570.0014830.00---
Upgrade
PB Ratio
4.875.276.76---
Upgrade
P/TBV Ratio
5.035.396.79---
Upgrade
Debt / Equity Ratio
0.020.010.010.02-0.04-0.68
Upgrade
Asset Turnover
---0.010.000.02
Upgrade
Quick Ratio
16.3016.2521.1516.060.560.86
Upgrade
Current Ratio
17.1016.7021.5716.530.570.88
Upgrade
Return on Equity (ROE)
-58.74%-44.97%-38.50%-1825.61%--
Upgrade
Return on Assets (ROA)
-38.33%-31.94%-26.12%-28.73%-23.78%-32.64%
Upgrade
Return on Capital (ROIC)
-39.57%-33.24%-27.09%-469.65%--
Upgrade
Earnings Yield
-16.68%-10.78%-4.62%---
Upgrade
FCF Yield
-14.34%-10.21%-4.31%---
Upgrade
Buyback Yield / Dilution
-2.28%-6.79%-36.26%-53.03%-2.65%-1.86%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.